Heparin Sodium (Heparin Sodium In Sodium Chloride)

Trade Name : HEPARIN SODIUM IN SODIUM CHLORIDE

Baxter Healthcare Corporation

INJECTION, SOLUTION

Strength 200 [USP'U]/100mL

HEPARIN SODIUM Anti-coagulant [EPC],Heparin [CS],Unfractionated Heparin [EPC]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Heparin Sodium (Heparin Sodium In Sodium Chloride) which is also known as HEPARIN SODIUM IN SODIUM CHLORIDE and Manufactured by Baxter Healthcare Corporation. It is available in strength of 200 [USP'U]/100mL per ml. Read more

Heparin Sodium (Heparin Sodium In Sodium Chloride) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • Heparin Sodium in Sodium Chloride Injection at a concentration of 2 units/mL is indicated as an anticoagulant to maintain catheter patency.
  • Heparin Sodium in Sodium Chloride Injection at a concentration of 2 units/mL is indicated as an anticoagulant to maintain catheter patency. ()
  • Infuse through intravenous catheter at a rate of 6 units per hour. ()
  • No data
  • The use of Heparin Sodium in Sodium Chloride Injection is contraindicated in patients with the following conditions:
  • Heparin Sodium in Sodium Chloride Injection is contraindicated in patients with the following conditions: ()
  • 5.2n- 5.3
  • No data
  • Hemmorhage:
  • HIT and HITT
  • The following clinically significant adverse reactions are described elsewhere in the labeling:
  • The following adverse reactions have been identified during post-approval use of heparin sodium. Because the reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency.
  • Hemorrhage
  • Hemorrhage is the chief complication that may result from heparin therapy [see ]. An overly prolonged clotting time or minor bleeding during therapy can usually be controlled by withdrawing the drug [see ]. Gastrointestinal or urinary tract bleeding during anticoagulant therapy may indicate the presence of an underlying occult lesion. Bleeding can occur at any site but certain specific hemorrhagic complications may be difficult to detect:
  • HIT and HITT, including delayed onset cases
  • Histamine-like reactions:
  • Hypersensitivity
  • Elevations of serum aminotransferases
  • Others:
  • Most common adverse reactions are: hemorrhage, HIT, thrombocytopenia, HIT and HITT, hypersensitivity, and elevations of aminotransferase levels. ()
  • www.fda.gov/medwatch.
  • Drugs that interfere with platelet aggregation or drugs that counteract coagulation may induce bleeding ()
  • Geriatric Use
  • 5.7
  • 8.5
  • Bleeding is the chief sign of heparin overdosage.
  • Neutralization of heparin effect:
  • When clinical circumstances (bleeding) require reversal of heparinization, protamine sulfate (1% solution) by slow infusion will neutralize heparin sodium. should be administered, in any 10-minute period. Each mg of protamine sulfate neutralizes approximately 100 USP heparin units. The amount of protamine required decreases over time as heparin is metabolized. Although the metabolism of heparin is complex, it may, for the purpose of choosing a protamine dose, be assumed to have a half-life of about 30 minutes after intravenous injection.
  • Because fatal reactions often resembling anaphylaxis have been reported with protamine, it should be given only when resuscitation techniques and treatment of anaphylactoid shock are readily available.
  • For additional information consult the labeling of Protamine Sulfate Injection.
  • Heparin is a heterogenous group of straight-chain anionic mucopolysaccharides, called glycosaminoglycans having anticoagulant properties. Although others may be present, the main sugars occurring in heparin are: (1) u03b1-L-iduronic acid 2-sulfate, (2) 2-deoxy-2-sulfamino-u03b1-D-glucose 6-sulfate, (3) u03b2-D-glucuronic acid, (4) 2-acetamido-2-deoxy-u03b1-D- glucose, and (5) u03b1-L-iduronic acid. These sugars are present in decreasing amounts, usually in the order (2) > (1) > (4) > (3) > (5), and are joined by glycosidic linkages, forming polymers of varying sizes. Heparin is strongly acidic because of its content of covalently linked sulfate and carboxylic acid groups. In heparin sodium, the acidic protons of the sulfate units are partially replaced by sodium ions.
  • Heparin Sodium in Sodium Chloride Injection is a buffered, sterile, nonpyrogenic solution of Heparin Sodium, USP derived from porcine intestinal mucosa, standardized for anticoagulant activity supplied in single dose containers for vascular administration. It contains no antimicrobial agents. The potency is determined by a biological assay using a USP reference standard based on units of heparin activity per milligram. Composition, osmolarity, pH and ionic concentration are shown in Table 1.
  • This VIAFLEX PLUS plastic container is fabricated from a specially formulated polyvinyl chloride (PL 146 Plastic). VIAFLEX PLUS on the container indicates the presence of a drug additive in a drug vehicle. The VIAFLEX PLUS plastic container system utilizes the same container as the VIAFLEX plastic container system. The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period, ., di-2-ethylhexyl phthalate (DEHP), up to 5 parts per million. However, the safety of the plastic has been confirmed in tests in animals according to USP biological tests for plastic containers as well as by tissue culture toxicity studies.
  • No data
  • No long-term studies in animals have been performed to evaluate carcinogenic potential of heparin. Also, no reproduction studies in animals have been performed concerning mutagenesis or impairment of fertility.
  • Heparin Sodium in Sodium Chloride Injection in VIAFLEX PLUS plastic container is supplied as follows:
  • Store at 25u00b0C (77u00b0F). Brief exposure up to 40u00b0C (104u00b0F) does not adversely affect the product. Avoid excessive heat.
  • Hemorrhage
  • Inform patients that it may take them longer than usual to stop bleeding, that they may bruise and/or bleed more easily when they are treated with heparin, and that they should report any unusual bleeding or bruising to their physician. Hemorrhage can occur at virtually any site in patients receiving heparin. Fatal hemorrhages have occurred [see ].
  • Prior to Surgery
  • Advise patients to inform physicians and dentists that they are receiving heparin before any surgery is scheduled [see ].
  • Heparin-Induced Thrombocytopenia
  • Inform patients of the risk of heparin-induced thrombocytopenia (HIT). HIT may progress to the development of venous and arterial thromboses, a condition known as heparin-induced thrombocytopenia with thrombosis (HITT). HIT and HITT can occur up to several weeks after the discontinuation of heparin therapy [seeu00a0].
  • Hypersensitivity
  • Inform patients that generalized hypersensitivity reactions have been reported. Necrosis of the skin has been reported at the site of subcutaneous injection of heparin [see , ].
  • Other Medications
  • Because of the risk of hemorrhage, advise patients to inform their physicians and dentists of all medications they are taking, including non-prescription medications, and before starting any new medication [see ].
  • Manufactured by:n n Deerfield, IL 60015 USA Printed in USA
  • Baxter, Viaflex and Viaflex Plus are trademarks of Baxter International Inc.
  • 07-19-00-0619
  • Rev. July 2019
  • Container Label
  • LOT EXP
  • NDC 0338-0431-03
  • Heparin
  • 1,000 units per 500 mLn
  • 500 mL STERILE SINGLE DOSE CONTAINER n- DO NOT ADDn- SUPPLEMENTARY MEDICATIONn- RX ONLY
  • Arrayn- Baxter
  • 1
  • 2
  • 3
  • 4
  • Carton Label
  • Lot: T123456n- QTY: 18-500mLn Exp: JAN 9999n- Code: 2B0953
  • NDC: 0338-0431-03
  • HEPARIN SODIUM IN 0.9% SODIUM
  • Bar Code(01)50303380431033(17)990100(21)000000000024(10)T123456
  • Bar Code(01)50303380431033(17)990100(21)000000000024(10)T123456
  • Container Label
  • LOT EXP
  • NDC 0338-0433-04n
  • Heparin
  • 2,000 units per 1,000 mL(2 units / mL)
  • 1,000 mL STERILE SINGLE DOSE CONTAINER n- DO NOT ADD SUPPLEMENTARY n- MEDICATIONn- RX ONLY
  • Arrayn- Baxter
  • 07-25-58-614
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Carton Label
  • Lot: T123456n- QTY: 12-1000mLn Exp: JAN 9999n- Code: 2B0944
  • NDC: 0338-0433-04
  • HEPARIN SODIUM IN 0.9% SODIUM
  • Bar Code(01)50303380433044(17)990100(21)000000000001(10)T123456
  • Bar Code(01)50303380433044(17)990100(21)000000000001(10)T123456
  • NDC 0338-0424-18n n
  • Heparin Sodium in 0.9% Sodium ChlorideInjection1,000 units per 500 mL(2 units / mL)
  • 500 mL STERILE SINGLE DOSE CONTAINERn n- DO NOT ADD SUPPLEMENTARY MEDICATIONn- RX ONLY
  • Arrayn- Baxtern- Array
  • AHB0953UA88-25-02-015
  • 1
  • 2
  • 3
  • 4
  • LOT ABCDEFGEXP DEC 2020n- QTY: 18-500 mLn NDC: 0338-0424-18CODE
  • HEPARIN SODIUM IN 0.9% SODIUMn- CHLORIDE INJECTION1,000 UNITS per 500 mL
  • Bar Code(17)201231(10)ABCDEFG
  • Bar Code(01)50303380424189(21)54097845545770
  • Baxter LogoBaxter Healthcare Corporation
  • 1 Baxter DriveOld Toongabbie, NSW 2146Australia
  • Bar CodeGTIN (01)50303380424189LOT (10)abcdefgSN(21)54097845545770880901229n

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Dossiers and Stability Studies

Dossiers and Stability Studies

STABILITY STUDIES STABILITY, BA / BE STUDIES Due to our active

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71247 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.